MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617096941 A) filed by Parsons, C. , Lowell on August 11, 2026, for Use Of Glycosaminoglycan Sulfated Polysaccharides Such As Sodium Pentosan Polysulfate In Combination With Permeation Agents To Treat Alzheimer'S Disease.
Inventor includes Parsons, C. , Lowell.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The present invention is directed to methods and compositions for the administration of sodium pentosan polysulfate and related glycosaminoglycans, particularly by oral administration, particularly in combination with administration of an intestinal penetration agent. The methods and compositions are suitable for treatment of neurodegenerative diseases such as, but not limited to, Alzheimer's disease. Methods and compositions according to the present invention can be used together with other agents suitable for treatment of neurodegenerative diseases such as, but not limited to, Alzheimer's disease.
Disclaimer: Curated by HT Syndication.
